|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis 显示文摘 | Reiter Y Pastan I | 1998 | Trends Biotech1998，16，12： | 2 |
| 2 | Modulation of the activity of the promoter of the human MDR1 gene by ras and p53显示文摘 | Ueda K Pastan I | 1992 | Science1992，4，： | 1 |
| 3 | Molecular cloning of mesothelin,a differentiation antigen present on mesothelim,mesotheliomas,and ovarian cancers显示文摘 | Chang K Pastan I | 1996 | Proc Natl Acad Sci USA1996，93，： | 1 |
| 4 | Biochemistry of muhidrug resistance mediated by the multidrug transporter显示文摘 | Gottesman MM Pastan I | 1993 | Annu Rev''Biochem1993，62，： | 1 |
| 5 | Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers 显示文摘 | Chang K Pastan I | 1996 | Proc Natl Acad Sci USA1996，93，1： | 1 |
| 6 | Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers 显示文摘 | Chang K Pastan I | 1996 | ProcNatlAcadSciUSA1996，993，1： | 1 |
| 7 | Improving antibody affinity by mimicking somatic hypermutation in vitro显示文摘 | Chowdhury PS Pastan I | 1999 | Nat Biotechnol1999，17，6： | 1 |
| 8 | Modulation of activity of the promoter of the human MDR1 gene by Ras and p53显示文摘 | Chin KV Ueda K Pastan I | 1992 | Science1992，255，5043： | 1 |
| 9 | Multidrug Resistance in Human Cancer显示文摘 | Gottesman MN | 1987 | New Engl J Med1987，316，： | 1 |
| 10 | Characterization of an MDR1 retroviral bicistronic vector for correction of X2 linked severe combined immunodeficiency显示文摘 | Kleiman SE Pastan I Puck JM | 1998 | Gene Ther1998，5，5： | 1 |
| 11 | Properties and purification of a glucose-regulatedprotein from chick embryo fibroblasts显示文摘 | Pastan I H Shiu RP | 1979 | Biochim Bopphys Acta1979，576，1： | 1 |
| 12 | TP-3 immtmotoxins improve antitumor activity in mice with osteosarcoma显示文摘 | Onda M Bruland S Pastan I | 2005 | Clin Orthop Relat Res2005，，430： | 1 |
| 13 | New immunotoxins targeting CD123,a stemcell antigen on acute myeloid leukemia cells 显示文摘 | Du X Ho M Pastan I | 2007 | J Immunother2007，30，6： | 1 |
| 14 | Immunotoxin therapy of cancer 显示文摘 | Pastan I Hassan R Fitzgerald D J and Kreitman R J | 2006 | Nature Reviews Cancer2006，6，7： | 1 |
| 15 | Multiple-drug resistance in human cancer显示文摘 | Pastan I Gottesman M | 1987 | N Engl J Med1987，316，22： | 1 |
| 16 | Generation of high titer anti-sera in rabbits by DNA immunization显示文摘 | Chowdhury PS Gallo M Pastan I | 2001 | J Immunol Methods2001，249，12： | 1 |
| 17 | Modulation of activity of the promotor of the human mdrl gene by Ras and p53 显示文摘 | Chin K V Ueda K Pastan I | 1992 | Science1992，255，5043： | 1 |
| 18 | Pseudomonas exotoxin: Chimeric toxins显示文摘 | Pastan I FitzGerald D | 1989 | J Biol Chem1989，264，15： | 1 |
| 19 | Cytotoxicity of folate-pseudomonas exotoxin conjugates toward tumor cel s,contribution of translocation domain显示文摘 | Leamon CP Pastan I Low PS | | 0，，33： | 1 |
| 20 | Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs显示文摘 | Berger EA Pastan I | 2010 | PLoS Pathog2010，6，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员